Literature DB >> 23948704

Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma.

H Vuarnesson1, R M Lupinacci, O Semoun, M Svrcek, C Julié, P Balladur, C Penna, J B Bachet, M Resche-Rigon, F Paye.   

Abstract

BACKGROUND: The accuracy of the assessment of the nodal status in resected cephalic pancreatic adenocarcinoma (PA) depends on the number of examined lymph nodes (NELN). This study assesses the impact of the NELN on N staging and survival and propose a minimal number of examined lymph nodes (MNELN) ensuring reliability of the pN status determination.
METHODS: 188 consecutive patients treated by pancreaticoduodenectomy (PD) for PA. Correlations between NELN and survivals of pN0 and pN1 groups and with the rate of pN1 patients were studied. A probability model based on the binomial law was built to estimate the MNELN able to detect pN1 patients with a sensitivity ≥ 95%.
RESULTS: Overall and disease free 5-year survivals were 27.2% and 24.6% respectively. 135 patients (71.8%) were staged pN1. The median NELN was 17 (range 0-68). Overall and disease free survivals of pN1 patients were not related to NELN. The influence of NELN on survival in pN0 patients due to stage migration did not reach significance. The probability model showed that a MNELN of 16 nodes was required to detect pN1 patients with a sensitivity of 95%.
CONCLUSION: A MNELN of 16 is required to assess pN status and should be considered as a quality criterion in future studies and trials on PD for PA.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lymphadenectomy; Pancreatic cancer; Pathology; Surgery; Surgical

Mesh:

Year:  2013        PMID: 23948704     DOI: 10.1016/j.ejso.2013.07.089

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  15 in total

Review 1.  Mesopancreas: A boundless structure, namely the rationale for dissection of the paraaortic area in pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Nadia Peparini
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

2.  Modification of the 8th AJCC staging system of pancreatic ductal adenocarcinoma.

Authors:  Teddy Sutardji Nagaria; Huamin Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-02       Impact factor: 7.293

3.  Three-dimensional computer-assisted dissection of pancreatic lymphatic anatomy on human fetuses: a step toward automatic image alignment.

Authors:  T Bardol; G Subsol; M-J Perez; D Genevieve; A Lamouroux; B Antoine; G Captier; M Prudhomme; M M Bertrand
Journal:  Surg Radiol Anat       Date:  2018-03-31       Impact factor: 1.246

4.  Increased pancreatic cancer survival with greater lymph node retrieval in the National Cancer Data Base.

Authors:  Carlo M Contreras; Chee Paul Lin; Robert A Oster; Sushanth Reddy; Thomas Wang; Selwyn Vickers; Martin Heslin
Journal:  Am J Surg       Date:  2017-07-01       Impact factor: 2.565

Review 5.  Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.

Authors:  Mehran Taherian; Huamin Wang
Journal:  Chin Clin Oncol       Date:  2022-06-16

6.  Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield.

Authors:  Rene Warschkow; Catherine Tsai; Nastassja Köhn; Suna Erdem; Bruno Schmied; Daniel P Nussbaum; Beat Gloor; Sascha A Müller; Dan Blazer; Mathias Worni
Journal:  Langenbecks Arch Surg       Date:  2020-02-10       Impact factor: 3.445

7.  Pathology of Treated Pancreatic Ductal Adenocarcinoma and Its Clinical Implications.

Authors:  Teddy Sutardji Nagaria; Hua Wang; Deyali Chatterjee; Huamin Wang
Journal:  Arch Pathol Lab Med       Date:  2020-07-01       Impact factor: 5.686

8.  The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.

Authors:  Shih-Chin Chen; Yi-Ming Shyr; Shu-Cheng Chou; Shin-E Wang
Journal:  World J Surg Oncol       Date:  2015-07-25       Impact factor: 2.754

9.  Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.

Authors:  Yu-Feng Li; Yu-Cheng Xiang; Qiu-Qiang Zhang; Wei-Lin Wang
Journal:  J Gastrointest Oncol       Date:  2020-08

10.  Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?

Authors:  G Lahat; N Lubezky; F Gerstenhaber; E Nizri; M Gysi; M Rozenek; Y Goichman; I Nachmany; R Nakache; I Wolf; J M Klausner
Journal:  World J Surg Oncol       Date:  2016-09-29       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.